Bibliography




Next: Summary and Common Themes Up: Other Cyclic Peptides Previous: Sex pilus subunits
-defensins
The defensins are a class of small Cys rich protein widely distributed
throughout plant, animal, insect, bird and mammal species including
humans [160]. It is believed that this class of
peptide is involved in innate immunity, conferring resistance to
pathogens via antimicrobial and anti-viral activity
[161]. Two families of, non-cyclic, defensins
have been discovered in mammals -- the and
defensins. These peptides range in size from 29 to 42 amino acids and
possess a three disulphide motif with different connectivity in each
class. Despite the different connectivity of the disulphide bonds
both class of defensin displays a similar overall fold
[162]. Recently a third class of neutrophil
expressed defensin was discovered in Macaque monkeys. This class of
defensin, termed rhesus
-defensin-1 (RTD-1), is distinguished
by possessing a high content of Arg and Cys residues and,
surprisingly, head-to-tail cyclisation of its peptide backbone
[163]. The 18 residue molecule is stabilised by three
disulphide bonds between its six Cys residues, however, unlike the
cyclotides, the disulphide bonds are arranged in a laddered topology.
![]() |
The solution structure of RTD-1 has been solved
[164] and, in contrast to the rigid, well
defined structures of SFTI-1 and the cyclotides, the structure of
RTD-1 appears to be somewhat flexible, displaying the ability to bend
about its central region (Figure 1.21). It is
interesting to contrast RTD-1 with SFTI-1, which is braced by a single
disulphide. In SFTI-1 the rigid structure shows no lateral
flexibility, probably as a consequence of its hydrogen bonding
network. Studies of the anti-microbial activity of RTD-1 show that
the peptide can bind to cell membranes in two different orientations
[165]. In only one of these orientations was weak
membrane thinning observed and it has been speculated that the
flexibility of RTD-1 allows it to bind to polar headgroups without the
disruption caused by the more rigid and
defensins
[166]. Consistent with this RTD-1 has been found to
possess very low cytotoxicity for human blood mononuclear cells
[167]. Hence the flexibility of RTD-1 may reflect its
physiological role, just as the rigid structure of SFTI-1 reflects its
role as a trypsin inhibitor. The flexibility of RTD also highlights
the importance of factors other than disulfides and backbone
cyclisation in conferring conformational rigidity.
The most fascinating aspect of the -defensins is their
biosynthesis. RT-PCR experiments designed to isolate the gene for
RTD-1 produced two genes, RTD-1a and RTD-1b, each of which encoded a
nine residue peptide that comprised half of the mature RTD-1
[163]. These genes encode a precursor with a signal sequence,
a pro-peptide, a nine residue mature segment that contains three of
the six Cys residues that comprise the mature peptide and a three
residue tail. Each gene is a homologue of a myeloid
-defensin,
differing only in the presence of a premature stop codon 3 residues
C-terminal to the final Cys residue (Figure 1.21) and
each gene possesses the typical 3-exon/2-intron structure of all known
myeloid defensin. Furthermore, the nucleotide sequence of each gene is
88% identical to that of a human
-defensin-like pseudogene.
It is fascinating, therefore, to contemplate that RTD-1 is derived
from two mutated halves of
-defensin genes.
![]() |
The biosynthetic pathway implied by this genetic structure is set out
in Figure 1.22. After signal sequence cleavage the nine
residue domain is cleaved both C-terminally and N-terminally to
release the tail and pro-peptide respectively. Either concomitantly
or subsequently to these cleavage reactions two ligation reactions are
required to tie the ends of the two peptides together to yield the
mature RTD-1. How the two different precursors are organised and
oriented to produce mature RTD-1 is not known although the formation
of disulphide bonds prior to the ligations would appear to be a
logical step. The biosynthetic pathway also allows for the production
of two other species of homodimeric conformations and both of these
peptides, RTD-2(1b/1b) and RTD-3 (1a/1a) have been identified in
rhesus monkey bone marrow [168] and peripheral
blood leukocytes in which they appear to be expressed in a 30:1:2
ratio of RTD 1-3 [169]. A third pro-RTD gene was
predicted by cDNA cloning [167] and recent studies
have provided evidence for expression of at least two of the possible
three additional -defensins [166].
Like most of the other cyclising reactions examined in this chapter the precursor of RTD both a C-terminal and an N-terminal cleavage reaction is required prior to cyclisation and once again the role that each of these segments plays in the reaction is unknown. The requirement for cleavage implies the presence of a protease and as discussed earlier, proteases can also catalyse the ligation of peptide bonds. Indeed in the case of the pilin subunit the cleavage and ligation are thought to be dependent on each other. In RTD the entire reaction is further complicated by the necessity of positioning the two independent halves of the mature peptide prior to the cyclising reaction. It is interesting to note however that the mutation that gave rise to the circular RTD was a stop codon in a characterised gene. It seems unlikely that this mutation and machinery to take advantage of this mutation would arise simultaneously, so once again the processing of RTD is likely to be the result of enzymes that are part of the regular biosynthetic pathways of the organism containing it. This consideration also adds strength to the notion that changes in the precursor sequence of linear peptides leads to cyclised proteins and hence the determination of a range of precursors that lead to cyclic peptides is of paramount importance in unravelling the general principles of protein cyclisation.




Next: Summary and Common Themes Up: Other Cyclic Peptides Previous: Sex pilus subunits Jason Mulvenna
2005-04-24